NCT01427803View on ClinicalTrials.gov

Actual Use Trial of Naproxen Sodium

PHASE3CompletedINTERVENTIONAL
Enrollment

778

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Pain
Interventions
DRUG

Naproxen Sodium ER (BAYH6689)

BAYH6689; oral tablet used as needed upon incidence of pain

Trial Locations (34)

21228

Baltimore

23192

Montpelier

23221

Richmond

35126

Pinson

35226

Hoover

55068

Rosemount

55113

Roseville

55304

Andover

55330

Elk River

55432

Fridley

64111

Kansas City

64485

Savannah

64504

Saint Joseph

66209

Overland Park

84010

Bountiful

84041

Layton

84075

Syracuse

84088

West Jordan

84102

Salt Lake City

84121

Salt Lake City

84401

Ogden

84737

Hurricane

85202

Mesa

87104

Albuquerque

87107

Albuquerque

87571

Taos

92054

Oceanside

92801

Anaheim

92886

Yorba Linda

98007

Bellevue

98028

Kenmore

98290

Snohomish

35111-3406

McCalla

55057-2434

Northfield

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT01427803 - Actual Use Trial of Naproxen Sodium | Biotech Hunter | Biotech Hunter